Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot,Randomized Controlled-trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease-translating Genomic Knowledge for Cardiovascular Prevention

NCT02109614 is registered in ClinicalTrials.gov with George Thanassoulis as lead sponsor.

NCT NCT02109614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02109614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot,Randomized Controlled-trial of Lipoprotein(a) Lowering for the Prevention of Aortic Valve Disease-translating Genomic Knowledge for Cardiovascular Prevention
Lead sponsor
George Thanassoulis
Phase
Phase 1
Overall status
Withdrawn
Start date
May 31, 2014
Completion date
September 30, 2017
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis and lipoprotein(a) levels